Cavitation Technologies, Inc. (CTi), a leader in nano-technology systems for fluid processing, has recently announced a pivotal transaction with Desmet Group, SA, marking a strategic shift towards water treatment opportunities. This deal, valued at approximately $1.5 million, involves the assignment of patents and trademarks related to vegetable oil refining to Desmet Group, SA, while CTi retains exclusive licenses for water and wastewater processing applications. This strategic move is aimed at bolstering CTi's financial standing and enabling it to tap into emerging markets in water remediation and treatment.
The transaction includes $1.1 million in cash and the forgiveness of about $400,000 in advances, providing CTi with the necessary capital to sustain operations and pursue business development without resorting to toxic financing. Neil Voloshin, CTi's CEO, highlighted the significance of this deal in securing the company's future and focusing on its core competencies in water treatment technologies.
CTi has already made strides in the water treatment sector, with a system installed at a major water remediation company in Texas and ongoing trials at Hacienda Farms in Canada. These initiatives showcase CTi's innovative approach to water treatment, offering chemical-free solutions that enhance oxygen levels, eliminate algae, and control bacterial growth, addressing critical challenges in agricultural and industrial settings.
Looking ahead, CTi is developing HydroPlasma, a cutting-edge technology that combines cavitation and cold plasma for more efficient water treatment. The company's collaboration with academic institutions underscores its commitment to innovation and its potential to lead in the sustainable water solutions market. With the Canadian water treatment market valued at $2.51 billion and the global cold plasma market expected to double by 2027, CTi is well-positioned to make a significant impact.
Despite the challenges faced by small technology companies, CTi's strategic focus on water treatment and its development of groundbreaking technologies like HydroPlasma demonstrate its dedication to increasing shareholder value and contributing to global sustainability efforts. For more information on CTi's technologies and market opportunities, visit https://www.cavitationtechnologies.com.
